Becoming a mother is one of the most beautiful experiences a woman can have. However, the joys of motherhood can be overshadowed by postpartum depression, a common mental health condition that affects many new mothers. According to the American Psychological Association, postpartum depression affects about 1 in 7 women, and symptoms can range from mild to severe.
Thankfully, there are innovative treatments available to help alleviate postpartum depression symptoms, including the use of Spravato (esketamine). Here’s what you need to know about this promising treatment option.
What is Spravato?
Spravato is a nasal spray medication that contains esketamine, a type of anesthetic that works by targeting the brain’s glutamate receptors. It was approved by the US Food and Drug Administration (FDA) in 2019 as a treatment for depression in adults who have tried other medications without success.
Spravato is administered in a healthcare provider’s office or clinic, and patients are monitored for at least two hours after taking the medication to ensure they are safe to leave.
How Does Spravato Help Treat Postpartum Depression?
Spravato has shown promise as a treatment option for postpartum depression. In fact, the FDA has granted it breakthrough therapy designation for this indication, which means that it has the potential to be a significant improvement over existing treatments.
Research studies have shown that Spravato can improve symptoms of depression in women with postpartum depression. In a randomized clinical trial, women who received Spravato showed significant improvement in their depression symptoms compared to those who received a placebo.
What Are the Benefits and Risks of Spravato?
Like all medications, Spravato has benefits and risks that need to be considered. The benefits of Spravato include:
- Effective treatment for postpartum depression
- Rapid onset of action, with some patients experiencing relief within hours
- Improved overall well-being and quality of life
The risks of Spravato include:
- Sedation, dissociation, and other adverse reactions, particularly during the monitoring period after administration
- Possible abuse and dependence, due to the medication’s potential for addiction
- Increased blood pressure and heart rate, which may require treatment
Is Spravato Right for You?
If you’re struggling with postpartum depression, it’s important to speak with your healthcare provider about treatment options. Spravato may be a good choice if other treatments have not worked for you or if you need rapid relief from your symptoms. Your healthcare provider can help you determine if Spravato is a good option for you and can monitor you for any potential side effects.
It’s also important to note that Spravato is just one part of a comprehensive treatment plan for postpartum depression. Other treatments may include therapy, antidepressant medications, lifestyle changes, and support from family and friends.
Why Choose Nao Medical for Spravato Treatment?
If you’re considering Spravato as a treatment option for postpartum depression, Nao Medical is an excellent choice. We are a modern healthcare company that offers high-quality, affordable care for communities, particularly in lower-income areas, and we have a strong focus on total whole body and mind care.
At Nao Medical, we offer Spravato treatment in a comfortable and welcoming clinic environment, with caring and knowledgeable staff who are dedicated to your well-being. We also offer other mental health services, as well as women’s health and nutrition services, to support your overall health and wellness.
If you’re interested in learning more about Spravato treatment for postpartum depression, please visit our website or book an appointment with one of our healthcare providers today. We’re here to help you feel better and live a happier, healthier life.
Q: What is postpartum depression?
A: Postpartum depression is a type of depression that can occur after giving birth. Symptoms may include feelings of sadness, anxiety, irritability, and difficulty bonding with the baby.
Q: What are the risk factors for postpartum depression?
A: Risk factors for postpartum depression include a history of depression or other mental health conditions, a lack of support from family and friends, stressful life events, and hormonal changes.
Q: Is Spravato covered by insurance?
A: Spravato is covered by many insurance plans, but coverage may vary depending on your specific plan. At Nao Medical, we accept most major insurance plans, and we also offer affordable self-pay options for patients who do not have insurance.
Q: How long does Spravato treatment take?
A: Spravato treatment typically involves two sessions per week for the first month, followed by weekly sessions for maintenance. Each session takes approximately two hours, including monitoring time.
Q: What should I expect during Spravato treatment?
A: During Spravato treatment, you will receive the medication through a nasal spray and be monitored for at least two hours after administration. You may experience sedation, dissociation, or other side effects, but these usually resolve within a few hours.
Q: Can I drive after Spravato treatment?
A: You should not drive or operate heavy machinery for at least 24 hours after Spravato treatment, as the medication can cause sedation and impair your ability to function normally.
Q: How do I book an appointment for Spravato treatment at Nao Medical?
A: To book an appointment for Spravato treatment at Nao Medical, please visit our website and select the “Book Appointment” button. You can also call our office directly to schedule an appointment with one of our healthcare providers.
Postpartum depression can be a difficult and overwhelming experience, but it’s important to remember that you’re not alone and that help is available. With innovative treatments like Spravato, you can feel better and improve your overall well-being. If you’re interested in learning more about Spravato or other treatment options for postpartum depression, please speak with your healthcare provider or book an appointment at Nao Medical today.